It is known that alcohol influences on human health and its effects are widely studied. Adipose tissue (AT) may be an important target of ethanol action. Data about the effect of ethanol on cytokine and pro-inflammatory enzymes' gene expression in adipocytes are scarce. The aim of the present study was to establish its effect on transcription of inflammatory markers IL-6, TNF-a, COX-2 and iNOS in cultured 3T3-L1 cells. MTT test was performed in order to determine ethanol effect on cell viability. Expression of selected genes was measured using two step quantitative PCR. Results were analyzed using 2 -DDCt method. Exposure of 3T3-L1 cells to increasing ethanol concentrations (0,125%-0,625%) resulted in gradual cell viability decline. Expression of all the genes studied was up-regulated upon ethanol treatment. In cells treated with 0,5% ethanol, there was a 4,8-(p<0,001), 6,3-(p<0,001), 5,5-(p<0,05) and 3,6-(p<0.05) fold increase of mRNA levels of IL-6, TNF-a, iNOS and COX-2, respectively, as compared with untreated controls. mRNA levels of the respective genes highly correlated with the applied ethanol concentration. In conclusion, our results show that ethanol treatment may increase the inflammatory potential of AT up-regulating expression of inflammatory cytokines IL-6 and TNF-a and inflammatory enzymes iNOS and COX-2 on transcription level.
INTRODUCTION
It is known that alcohol influences on human health and its effects are widely studied. Deleterious consequences from excessive consumption are associated with elevated morbidity and mortality. Other studies have demonstrated that moderate alcohol consumption may improve human health, especially in regard of cardiovascular diseases (12) . Additionally, alcohol application for amelioration of certain inflammatory conditions is a popular practice in folk medicine. This may be attributed to its ability to interfere with molecular mechanisms underlying inflammatory response in variety of cell types. A number of experimental data in vitro and in vivo demonstrates that ethanol can act as anti-inflammatory agent diminishing the ability of different stimuli, such as bacterial lipopolysaccharides to up-regulate the expression of the inflammatory cytokines IL-6 and TNF-a (8) and iNOS (18) . However, when applied in the absence of inflammatory stimuli ethanol induces production of pro-inflammatory cytokines IL-6 and TNF-a and of the inflammatory enzymes iNOS and COX-2 (14, 21) . Adipose tissue (AT) may be an important target of ethanol action. Few publications focus on that. In human primary adipose cell line, Wandler et al. (2008) establish a complex time-dependent change in IL-6 release after ethanol treatment, where protein levels recover to initial state after a fall 1,5 h after treatment. In vivo chronic ethanol consumption increases IL-6 and TNF-a levels in rat AT (11) . In man, increased IL-6 and TNF-a levels in AT correlate with alcohol-induced liver injury (15) . Data about the effect of ethanol on cytokine and pro-inflammatory enzymes' gene expression in adipocytes are scarce. Pre-adipocytes along with mature adipocytes, fibroblasts and macrophages, the cell types found in AT, actively participate in AT secretory function (9), thus participating in whole body metabolism by secretion of a variety of adipokines. TNF-a and IL-6 are among the numerous pro-inflammatory factors constitutively expressed in AT (3). Increased IL-6 and TNF-a levels are regarded as a hallmark of chronic inflammation accompanying obesity and preceding metabolic diseases such as insulin resistance, type 2 diabetes mellitus, atherosclerosis and cardiovascular disease (4) . Originally identified as a macrophage product, TNF-a was the first AT-secreted product proposed to represent a molecular link between obesity and insulin resistance (10) . IL-6 is considered to be a stress-induced cytokine with varying effects on a variety of tissues. As an inflammatory mediator IL-6 stimulates acute phase protein synthesis (19) . As much as one third of total circulating IL-6 concentrations originate from AT (7) and its plasma concentration highly correlates with body mass and inversely to insulin sensitivity (2) . iNOS is the inducible isoform of the enzyme producing NO, which is an important mediator of many processes, including inflammation. Its expression may be induced by stimuli such as lipopolysaccharides (17) . COX-2 is the rate-limiting enzyme in production of a range of local mediators involved in various of processes, including local inflammation. As AT in obesity is implicated in low grade inflammation, investigations of the effects of ethanol on the expression of cytokines and inflammatory enzymes in cultured preadipocytes could help formulating new diet and social behavior recommendations to combat obesity.
MATERIAL AND METHODS

Cell culture
3T3-L1 cells were obtained from the American Type Culture Collection (ATCC). Preadipocytes were cultured in 75cm 2 flasks at 37°C in a humidified chamber with 5% CO 2 atmosphere. Nutrient medium comprised phenol red-containing Dulbecco's modified Eagle's medium (DMEM, Lonza) with 4,5 g/L glucose, L-glutamine and supplemented with fetal bovine serum (FBS, Sigma-Aldrich) to final concentration of 10% and penicillin/streptomycin mixture to final concentration of 100U/mL each.
Cytotoxicity assay
Viability of ethanol-treated cells was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The assay was based on the ability of viable cells to reduce the yellow MTT to purple insoluble formazan. Briefly 100 mL of MTT solution in PBS (pH=7,4) at concentration of 2 mg/mL was added to each well. After a 4-h incubation of the plates at dark the medium was removed and 1 mL of DMSO was added to each well to lyse the cells and dissolve the reduced MTT. After thorough mixing, 200 mL were transferred to 96 plates and the absorbance at l max =550 nm was determined using Synergy 2 plate reader (BioTek). Viability of treated cells was presented in percentage of the viability of the non-treated cells, which is considered 100%. All the treatments were performed in triplicate. Data were presented as mean±SD.
Experimental procedure
Cells were collected and seeded in 6 well flasks at density 2x10 5 cells/well. After overnight incubation cells were treated with ethanol in different concentrations and dissolved in phenol red free DMEM (Lonza) without any supplements. Cells were incubated either 20 h-long for MTT test, or 24 h-long for gene expression determination when RNA was isolated from harvested cells. (Table 1) were designed using real-time PCR Gene Expression Design Tool (http://eu.idtdna.com/Scitools/Applications/RealTimePCR/Default.aspx) and commercially synthesized (Alpha DNA, Canada). As a template for real-time PCR 0,39 mL of cDNA was amplified in 5 mL final volume. Final primers' concentration was 300 nM. Analysis of the gene expression was performed using GreenMasterMix (Genaxxon) containing Eva Green fluorescent dye. Reactions were performed in 96 well plates. Gene expression levels were calculated using the 2 -DDCt method (13) and expressed as relative units (RU) compared to the untreated controls where the level of gene expression of interest was considered to be equal to 1. Results were presented as mean of the RU±SEM. Beta-actin was used as endogenous control. Amplification products were examined for nonspecific amplification by including an additional denaturation step in the real-time thermal cycler protocol. All the measurements were performed at least in triplicate.
Gene expression analysis
Statistical analysis
Statistical analyses were performed using Microsoft Excell Office 2007 software. Differences between two groups were analyzed by unpaired two-tailed Student's t-tests. A p value less than 0,05 was considered significant.
RESULTS
Ethanol cytotoxicity in 3T3-L1 cells
Exposure of 3T3-L1 cells to increasing ethanol concentrations (0,125%-0,625%) resulted in gradual cell viability diminution (Fig. 1) .
Ethanol-induced IL-6 and TNF-a cytokine gene expression in 3T3-L1 cells
Ethanol applied on 3T3-L1 preadipocytes enhanced IL-6 gene expression (Fig. 2) . Final ethanol concentration of 0,25% stimulated transcription of IL-6 gene by 44% (p<0,01) and that one of 0,5% -even by 480% (p<0,001) as compared to untreated controls. Twofold increase of ethanol concentration (from 0,25% to 0,5%) enhanced the gene expression levels by more than three times (p<0,001) representing a concentration-dependent manner of action. TNF-a gene expression was also up-regulated upon ethanol treatment (Fig. 3) . Ethanol concentrations of 0,125% and 0,25% increased mRNA levels by 54% (p=0,015) and 71% (p<0,05), respectively. The highest concentration of ethanol (of 0,5%) increased by more than six times TNF-a gene transcription as compared to untreated controls (p<0,001). While no difference was established between the effect of the lower concentrations (0,125% and 0,25%), the twofold elevation of ethanol concentration from 0,25% up to 0,5% resulted in an about 3,7-fold increase of TNF-a mRNA levels (p<0.001). mRNA levels of the respective genes highly correlated with the applied ethanol concentration (r=0,92 for IL-6 and r=0,93 for TNF-a). 
Ethanol-induced iNOS and COX-2 enzyme gene expression in 3T3-L1 cells
Similarly as with IL-6 and TNF-a cytokine gene expression, ethanol treatment stimulated iNOS and COX-2 enzyme transcription levels. After 3T3-L1 cell exposure to increasing ethanol concentrations, iNOS mRNA levels were higher than those in untreated controls by 57%, 95% and 554%, respectively (p<0,05) (Fig. 4) . Twofold increase of ethanol concentration (from 0,25% to 0,5%) increased iNOS mRNA levels by three times (p<0,01). Transcription of COX-2 in 3T3-L1 preadipocytes was stimulated upon ethanol treatment, too (Fig. 5) .
Ethanol in concentrations of 0,125%, 0,25% and 0,5% increased mRNA levels by 13%, 40% (p<0,01) and 365% (p<0,05), respectively as compared to untreated controls. Its twofold increase resulted in higher mRNA levels by 24% (0,125% vs 0,25%; p<0,05) and by 260% (0,25% vs 0,5%; p<0,05), respectively. mRNA levels correlated with ethanol concentration (r=0,95 for iNOS and r=0,93 for COX-2).
DISCUSSION
The present study demonstrates for the first time data about the stimulatory effect of ethanol on IL-6 and TNF-a cytokines and COX-2 and iNOS pro-inflammatory enzymes expression in cultured 3T3-L1 preadipocytes on transcriptional level after 24 h exposure to different ethanol concentrations.
The volumetric ethanol concentrations of 0,125%, 0,25% and 0,5% selected by us correspond to 21,4 mM, 42,8 mM and 85,6 mM ethanol, respectively, and are physiologically relevant in vivo (5). Furthermore, cytotoxicity MTT test proves a gradual diminution of cell viability in the chosen ethanol concentration range (Fig. 1) . Ethanol up-regulated the expression of IL-6 and TNF-a in 3T3-L1 preadipocytes and mRNA levels of the respective genes highly correlated with the applied ethanol concentration. preadipocytes by increasing the expression of inflammatory markers. The effect of ethanol on cytokine and inflammatory enzyme gene expression could be attributed to its ability to modify signaling pathways. Transcription of IL-6 and TNF-a and inflammatory enzymes COX-2 and iNOX is mediated by NF-kB (1). It has been shown that NF-kB activity and transcription are increased after ethanol treatment (5).
As a transcription factor NF-kB is a target of multiple signaling pathways, including Toll-like Receptors (TLRs) mediated signalization. It has been demonstrated that the effect of ethanol on TNF-a, COX-2 and iNOS production is mediated by TLR (6). As both adipocytes and preadipocytes express a broad set of TLRs (16), they could respond to specific stimulation by cytokine production. Further investigations of ethanol effects on other molecules involved in these signal pathways, especially in AT, would elucidate the mechanisms of ethanol pro-inflammatory action.
CONCLUSIONS
Our present study undoubtedly shows that ethanol may increase the inflammatory potential of AT up-regulating expression of inflammatory cytokines IL-6 and TNF-a and inflammatory enzymes iNOS and COX-2 on transcription level. 
Fig. 5. COX-2 expression levels in 3T3-
